InvestorsHub Logo

cellardwellar

08/06/21 11:45 AM

#369188 RE: Justfactsmam #369180

You just knocked it out of the park. Great work

Rdunn88

08/06/21 11:51 AM

#369190 RE: Justfactsmam #369180

Hilarious, B has never failed a trial... What's definition for success?


INVESTORS should not forget...BRILACIDIN HAS NEVER FAILED A CLINICAL TRIAL...AND...IT IS A FRANCHISE...for MULTIPLE INDICATIONS...

Pipilongstocking

08/06/21 12:26 PM

#369196 RE: Justfactsmam #369180

Thanks for a great post!!

farrell90

08/06/21 12:49 PM

#369199 RE: Justfactsmam #369180

Nice review. At this point IPIX should continue on its prudent course of carefully and thoughtfully engaging the FDA. An example of aggressive promotion drawing the ire of the FDA can be seen with Cytodyn.

The FDA's letter to Cytodyn was a warning to all pharma companies.

https://www.fda.gov/drugs/drug-safety-and-availability/statement-leronlimab

The fallout from the FDA slap down continues to plague the company. Last week Cytodyn received subpoenas from the SEC and DOJ regarding Leronlimab's promotion.

https://seekingalpha.com/news/3724193-cytodyn-receives-sec-doj-subpoenas-related-to-leronlimab-as-a-covid-19-treatment

The above is addition to lawsuits from class action attorneys and shareholders.

https://www.fiercebiotech.com/biotech/cytodyn-shares-plummet-after-being-accused-by-fda-cherry-picking-covid-19-data

https://www.cnbc.com/2021/07/24/large-shareholder-group-calls-for-a-board-overhaul-at-pharma-company-cytodyn.html

GLTA Farrell